Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro (Q42825221)

8 November 2017

title

Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro (English)

1 reference

8 November 2017

0 references

1 reference

8 November 2017

Bente Klarlund Pedersen

1 reference

8 November 2017

Petersen EW

1 reference

8 November 2017

Carey AL

1 reference

8 November 2017

Steinberg GR

1 reference

8 November 2017

Macaulay SL

1 reference

8 November 2017

Febbraio MA

1 reference

8 November 2017

language of work or name

1 reference

21 September 2004

1 reference

American Journal of Physiology - Endocrinology and Metabolism

8 November 2017

published in

1 reference

8 November 2017

volume

288

1 reference

8 November 2017

1 reference

8 November 2017

page(s)

E155-62

1 reference

Effects of 22K or 20K human growth hormone on lipolysis, leptin production in adipocytes in the presence and absence of human growth hormone binding protein

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Additive effects of cortisol and growth hormone on regional and systemic lipolysis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Fuel selection in human skeletal muscle in insulin resistance: a reexamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Metabolic effects of interleukin-6 in human splanchnic and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Mechanism of free fatty acid-induced insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Interleukin-6 induces cellular insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-alpha levels after prolonged running.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Human skeletal muscle fatty acid and glycerol metabolism during rest, exercise and recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Interleukin-6 stimulates lipolysis and fat oxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

The therapeutic potential of interleukin-6 in treating obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

Interleukin-6-deficient mice develop mature-onset obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00257.2004

10.1152/AJPENDO.00257.2004

21 January 2018

Identifiers

DOI

1 reference

8 November 2017

1 reference